ZLATOMICS FINTECH

The Future of Scientific Funding

Recovering Capital Lost
in the Biotech Economy

Billions in biotech investment disappear each year via stalled research and shelved assets. Zlatomics Fintech brings that capital back.

Secure Early Access

Our Mission

We envision a biotech economy where no validated science goes to waste — where every researcher's data has a financial future, and where capital flows back into discovery rather than disappearing from it.

The Problem

01 — The Problem

Capital That Disappears

Conventional finance has no framework for assets that don't fit a binary outcome. When a drug trial fails or a program is shelved, the accounting closes — even when the underlying data, IP, or science retains real value. The system isn't designed to find it.

The result: investors absorb total losses, science loses momentum, and capital leaves the ecosystem permanently.
02 — The Solution

A Recovery Mechanism

Zlatomics Fintech applies a proprietary framework to recapture value from biotech assets the market has written off — re-engaging dormant assets and channeling recovered capital back into the productive economy.

When your data is transformed into capital, every scientist with generated data can profit.

How It Works

1
Identify Lost Capital

We identify undervalued and written-off biotech assets — failed programs, shelved IP, and stranded scientific work with latent economic value.

Asset Discovery
2
Apply Our Framework

Our proprietary mechanism re-evaluates these assets through a new lens, opening value that conventional finance overlooks.

Proprietary Process
3
Return Capital to the Economy

Recovered value is channeled back into productive use — reinvestment in science, returns to stakeholders, and a healthier, more efficient biotech ecosystem.

Economic Recovery

Interested in What We're Building?

Request more information, updates, and early access.